Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Saxena

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|June 24, 2014
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitorsGanesh Samala, Radhika Nallangi, Parthiban Brindha Devi, et al.
Journal of Molecular Graphics & Modelling|June 6, 2015
Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydrataseGuilherme O Petersen, Shalini Saxena, Janupally Renuka, et al.
International Journal of Mycobacteriology|January 21, 2016
Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59]Ganesh Samala, Shruti Singh Kakan, Radhika Nallangi, et al.
Chemical Biology & Drug Design|September 9, 2015
Design and Development of Mycobacterium tuberculosis Lysine ɛ-Aminotransferase Inhibitors for Latent Tuberculosis InfectionBrindha Devi Parthiban, Shalini Saxena, Manoj Chandran, et al.
Chemmedchem|August 27, 2014
Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitorsParthiban Brindha Devi, Ganesh Samala, Jonnalagadda Padma Sridevi, et al.
Bioorganic & Medicinal Chemistry|October 6, 2014
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhAGanesh S Pedgaonkar, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, et al.
European Journal of Medicinal Chemistry|September 15, 2014
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosisGanesh S Pedgaonkar, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, et al.
Organic & Biomolecular Chemistry|January 9, 2015
Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profilingVariam Ullas Jeankumar, Rudraraju Srilakshmi Reshma, Renuka Janupally, et al.
Bioorganic & Medicinal Chemistry|April 9, 2017
Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitorsRudraraju Srilakshmi Reshma, Variam Ullas Jeankumar, Nidhi Kapoor, et al.
Tuberculosis (Edinburgh, Scotland)|August 25, 2015
Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosisParthiban Brindha Devi, Jonnalagadda Padma Sridevi, Shruti Singh Kakan, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|June 24, 2014
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitorsGanesh Samala, Radhika Nallangi, Parthiban Brindha Devi, et al.
Journal of Molecular Graphics & Modelling|June 6, 2015
Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydrataseGuilherme O Petersen, Shalini Saxena, Janupally Renuka, et al.
International Journal of Mycobacteriology|January 21, 2016
Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59]Ganesh Samala, Shruti Singh Kakan, Radhika Nallangi, et al.
Chemical Biology & Drug Design|September 9, 2015
Design and Development of Mycobacterium tuberculosis Lysine ɛ-Aminotransferase Inhibitors for Latent Tuberculosis InfectionBrindha Devi Parthiban, Shalini Saxena, Manoj Chandran, et al.
Chemmedchem|August 27, 2014
Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitorsParthiban Brindha Devi, Ganesh Samala, Jonnalagadda Padma Sridevi, et al.
Bioorganic & Medicinal Chemistry|October 6, 2014
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhAGanesh S Pedgaonkar, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, et al.
European Journal of Medicinal Chemistry|September 15, 2014
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosisGanesh S Pedgaonkar, Jonnalagadda Padma Sridevi, Variam Ullas Jeankumar, et al.
Organic & Biomolecular Chemistry|January 9, 2015
Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profilingVariam Ullas Jeankumar, Rudraraju Srilakshmi Reshma, Renuka Janupally, et al.
Bioorganic & Medicinal Chemistry|April 9, 2017
Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitorsRudraraju Srilakshmi Reshma, Variam Ullas Jeankumar, Nidhi Kapoor, et al.
Tuberculosis (Edinburgh, Scotland)|August 25, 2015
Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosisParthiban Brindha Devi, Jonnalagadda Padma Sridevi, Shruti Singh Kakan, et al.
Pageof 5